Evidence map›Paper›PMID 37661455›Full record

ArticleInternal medicine (Tokyo, Japan)2024

Participant Selection from the General Japanese Population for Pulmonary Function Tests Using a Questionnaire on Symptoms and Smoking Habits during Annual Health Checkups: The Yamagata-Takahata Study.

Sumito Inoue, Yoko Shibata, Osamu Miyazaki, Toshinari Hanawa, Yukihiro Minegishi, Hiroaki Murano, Kento Sato, Maki Kobayashi, Masamichi Sato, Takako Nemoto and 5 more

Open access · diamondAbstract read
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.3field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 1 country.

Sumito InoueDepartment of Cardiology, Pulmonology and Nephrology, Yamagata University Faculty of Medicine, Japan.
Yoko ShibataDepartment of Pulmonary Medicine, Fukushima Medical University, Japan.
Osamu MiyazakiDepartment of Cardiology, Pulmonology and Nephrology, Yamagata University Faculty of Medicine, Japan.
Toshinari HanawaDepartment of Cardiology, Pulmonology and Nephrology, Yamagata University Faculty of Medicine, Japan.
Yukihiro MinegishiDepartment of Cardiology, Pulmonology and Nephrology, Yamagata University Faculty of Medicine, Japan.
Hiroaki MuranoDepartment of Cardiology, Pulmonology and Nephrology, Yamagata University Faculty of Medicine, Japan.
Kento SatoDepartment of Cardiology, Pulmonology and Nephrology, Yamagata University Faculty of Medicine, Japan.
Maki KobayashiDepartment of Cardiology, Pulmonology and Nephrology, Yamagata University Faculty of Medicine, Japan.
Masamichi SatoDepartment of Cardiology, Pulmonology and Nephrology, Yamagata University Faculty of Medicine, Japan.
Takako NemotoDepartment of Cardiology, Pulmonology and Nephrology, Yamagata University Faculty of Medicine, Japan.
Michiko NishiwakiDepartment of Cardiology, Pulmonology and Nephrology, Yamagata University Faculty of Medicine, Japan.
Akira IgarashiDepartment of Cardiology, Pulmonology and Nephrology, Yamagata University Faculty of Medicine, Japan.
Kazunobu IchikawaDepartment of Cardiology, Pulmonology and Nephrology, Yamagata University Faculty of Medicine, Japan.
Tetsu WatanabeDepartment of Cardiology, Pulmonology and Nephrology, Yamagata University Faculty of Medicine, Japan.
Masafumi WatanabeDepartment of Cardiology, Pulmonology and Nephrology, Yamagata University Faculty of Medicine, Japan.
Yamagata University · JPFukushima Medical University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective Pulmonary function tests are essential for diagnosing respiratory diseases, such as chronic obstructive pulmonary disease (COPD), but are typically not performed in Japan during annual health checkups, which hinders the early diagnosis of respiratory diseases. Methods Individuals who agreed to participate in the Yamagata-Takahata study during medical checkups in Takahata (Yamagata Prefecture, Japan) in 2011 were examined. We interviewed 669 participants (49.0% men; mean age, 67.7 years old) regarding their respiratory symptoms and smoking habits and performed pulmonary function tests during the study. Results Based on pulmonary function test results, 141 participants had pulmonary dysfunction, and 115 had obstructive pulmonary dysfunction. The risk of respiratory dysfunction, particularly obstructive respiratory dysfunction, was examined by referring to a questionnaire tool for an early COPD diagnosis. The associations between age, the smoking history, respiratory symptoms, and obstructive respiratory dysfunction were evaluated. Obstructive respiratory dysfunction was found in 17.6% of participants ≥50 years old and 19.5% ≥60 years old, 30.3% had a smoking history, and 32.8% had respiratory symptoms. Furthermore, the participants with multiple factors had a higher probability of obstructive respiratory dysfunction. Conclusion Subjects with obstructive pulmonary dysfunction are expected to be efficiently identified by extracting individuals by age and smoking habit and through a respiratory symptom questionnaire, although pulmonary function tests cannot be performed for all individuals during health checkups.

Indexed as

Pulmonary Disease, Chronic ObstructiveSmokingAgedEast Asian PeopleFemaleHumansJapanMaleMiddle AgedRespiratory Function TestsCOPD population screenerdiagnosis of respiratory diseasepopulation-based epidemiologypulmonary function testYamagata-Takahata study

Identifiers

PMID37661455
PMCPMC11081890
OpenAlexW4386321157

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.